| P/E (FY) | 6.0 | Sales (TTM) | €1.6M |
| Earnings (TTM) | €219.0M | ROE | 12.45% |
| Net Margin | 13410.96% | ROIC | 15.29% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | 4.27% | Sales Growth 3Y | −82.82% |
Gimv NV is a private equity and venture capital firm making both direct and fund-of-funds investments. It backs companies across consumer, health and care, smart industries, and sustainable cities themes, using approaches that range from seed and growth capital to buyouts and recapitalizations, taking either majority or minority stakes. Founded in 1980 and based in Antwerp, Belgium, the firm focuses on businesses headquartered in the Benelux, France, and Germany, with additional offices across Europe.
| Market Cap | $1.48B | Trading Days | 3794 |
| 52W High | 50.10 |
| 52W Low | 41.80 |
| % Off High | −11.08% |
| YTD | −0.22% | 1Y | 5.32% |
| 3Y | 7.74% | 5Y | −16.73% |
| 10Y | −9.04% | Since incept. (ann.) | 0.38% |
| Ann. Volatility (1Y) | 19.02% | Ann. Volatility (3Y) | 20.25% |
| Sharpe (1Y) | 0.37 | Sharpe (3Y) | 0.21 |
| Max Drawdown (1Y) | −12.47% | Max Drawdown (3Y) | −24.68% |
| Beta (3Y, vs SPY) | 0.85 |
No same-industry peers in the universe for GIMB.BR.
